Rates of cardiovascular disease and major adverse cardiovascular events in patients with psoriatic arthritis compared to patients without psoriatic arthritis

Journal of Clinical Rheumatology

Volumn 21, Issue 8, 2015, Pages 405-410

  Li, Lin ^a   Hagberg, Katrina Wilcox ^a   Peng, Michael ^b   Shah, Kamal ^b   Paris, Maria ^b   Jick, Susan ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

Cardiovascular disease; Major adverse cardiovascular events; Psoriatic arthritis

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SEX DIFFERENCE; UNITED KINGDOM; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; COMPLICATION; INFORMATION PROCESSING;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIOLOGICAL PRODUCTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATA COLLECTION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; UNITED KINGDOM;

EID: 84948717905     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000306     Document Type: Article

References (12)

1. Tobin AM, Veale DJ, Fitzgerald O, et al. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol. 2010;37:1386-1394.
2. Jamnitski A, Symmons D, Peters MJ, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72:211-216.
3. Han C, Robinson DW Jr, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167-2172.
4. Gladman DD, Ang M, Su L, et al. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009;68:1131-1135.
5. Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74:326-332. doi: 10.1136/annrheumdis-2014-205675.
6. Ernste FC, Sánchez-Menéndez M, Wilton KM, et al. Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based, cohort study. Arthritis Care Res (Hoboken). 2015;67:1015-1021. doi: 10.1002/acr.22536.
7. Gulati AM, Semb AG, Rollefstad S, et al. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study. Ann Rheum Dis. 2015. pii: annrheumdis-2014-206824. doi: 10.1136/annrheumdis-2014-206824. [Epub ahead of print].
8. Lawson DH, Sherman V, Hollowell J. The General Practice Research Database. Scientific and Ethical Advisory Group. QJM. 1998;91:445-452.
9. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerized data resource in the United Kingdom. BMJ. 1991;302:766-768.
10. Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf. 1992;1:347-349.
11. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23:686-689.
12. Edson-Heredia E, Zhu B, Lefevre C, et al. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol. 2015;29:955-963. doi: 10.1111/jdv.12742.